Induction of tenascin in rat lungs undergoing bleomycin-induced pulmonary fibrosis

被引:34
|
作者
Zhao, Y
Young, SL
McIntosh, JC
机构
[1] Duke Univ, Med Ctr, Dept Med & Pediat, Durham, NC 27710 USA
[2] Durham Vet Affairs Med Ctr, Res Serv, Durham, NC 27710 USA
关键词
lung injury; inflammation; extracellular matrix;
D O I
10.1152/ajplung.1998.274.6.L1049
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Lung injury induced by bleomycin is associated with early inflammation and subsequent excessive deposition of extracellular matrix. In the present study, we investigated the expression of extracellular matrix glycoprotein tenascin (TN) during pulmonary injury induced by bleomycin. After the initial lung injury induced by intratracheal bleomycin instillation, TN and collagen type III(COL III) mRNAs were greatly induced. The pattern of induction of TN was distinct from that of COL III. TN was primarily induced during the early inflammatory phase, whereas the increase in COL III synthesis continued during the reparative phase. The induction and localization of TN mRNA during bleomycin-induced pulmonary injury were also examined by in situ hybridization. TN mRNA was focally induced in rat lungs 3 days after bleomycin administration. Induction of TN mRNA was spatially restricted in the areas of tissue inflammation. The interstitial cells in alveolar septal walls and secondary septal tips in the areas of tissue damage were the major source of TN mRNA production. Expression of TN mRNA was decreased as the inflammation attenuated and development of fibrosis proceeded. Immunocytochemical analyses of TN protein distribution in the lung yielded corroborative results. Immunoreactive TN protein was found in a patchy distribution in alveolar septal walls and secondary septal tips in the areas of damaged tissues. This study demonstrated that TN is a unique early-response extracellular matrix component to bleomycin-induced pulmonary injury and is induced at the sites of the inflammation, suggesting a potential role of TN as a modulator of pulmonary inflammation and repair.
引用
收藏
页码:L1049 / L1057
页数:9
相关论文
共 50 条
  • [21] Prolonged distribution of aerosolized PEGylated liposomes in the lungs of mice with bleomycin-induced pulmonary fibrosis
    Togami, Kohei
    Maruta, Yuki
    Nanbu, Mao
    Tada, Hitoshi
    Chono, Sumio
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2020, 46 (11) : 1873 - 1880
  • [22] INHIBITION OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS BY LIPOPOLYSACCHARIDE
    PHAN, SH
    FANTONE, JC
    LABORATORY INVESTIGATION, 1984, 50 (05) : 587 - 591
  • [23] BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN THE BEIGE MOUSE
    PHAN, SH
    SCHRIER, D
    MCGARRY, B
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 617 - 617
  • [24] PATHOGENESIS OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN MICE
    ADAMSON, IYR
    BOWDEN, DH
    AMERICAN JOURNAL OF PATHOLOGY, 1974, 77 (02): : 185 - 199
  • [25] A Bleomycin-Induced Pulmonary Fibrosis Model in Mice
    Fujimura, Hiroshi
    Mitsuishi, Mikio
    Morizumi, Kousuke
    Katayama, Seiichi
    Atai, Hiroshi
    Nishi, Katsuhide
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 158P - 158P
  • [26] AN INVITRO MODEL FOR BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    KIRCHHOFER, D
    REINHARDT, CA
    ZBINDEN, G
    EXPERIENTIA, 1986, 42 (06): : 651 - 651
  • [27] Novel biomarkers in bleomycin-induced pulmonary fibrosis
    Fernandez, Isis
    Amarie, Oana
    Yildirim, Oender
    Koenigshoff, Melanie
    Eickelberg, Oliver
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [28] Attenuation of bleomycin-induced pulmonary fibrosis by follistatin
    Aoki, F
    Kurabayashi, M
    Hasegawa, Y
    Kojima, I
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (06) : 713 - 720
  • [29] THE EFFECT OF LIPOPOLYSACCHARIDE ON BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    PHAN, SH
    FANTONE, JC
    MCGARRY, B
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1982, 125 (04): : 54 - 54
  • [30] CAPILLARY REMODELING IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    SCHRAUFNAGEL, DE
    MEHTA, D
    HARSHBARGER, R
    TREVIRANUS, K
    WANG, NS
    AMERICAN JOURNAL OF PATHOLOGY, 1986, 125 (01): : 97 - 106